Jeff Kosseff
Section 230’s Evolution Over Two Decades
January 18, 2017
Ido Kilovaty
Towards a Contextual Approach
January 18, 2017
Shawn A. Johnson
Considering the Need for a Cost-Benefits Analysis in the FTC’s Deception Framework
January 18, 2017
Kevin Khachatryan
Reforms of Pharmaceutical Innovation
January 18, 2017
Kirsten Martin, Helen Nissenbaum
an Empirical Test Using Context to Expose Confounding Variables
January 18, 2017